Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 61.69%104.3K | 0 | 71.32K | 93.51%95.17K | 0 | 64.51K | 688.10%30.67K | 0 | -27.85%49.18K | 47.30%41.4K |
| Operating revenue | 61.69%104.3K | --0 | --71.32K | 93.51%95.17K | --0 | --64.51K | 688.10%30.67K | --0 | -27.85%49.18K | 47.30%41.4K |
| Cost of revenue | 0 | 0 | 0 | -34.85%6.75K | -99.64%21 | |||||
| Gross profit | 124.28%95.17K | 0 | 1,058.78%64.51K | 688.10%30.67K | -26.59%42.43K | 86.19%41.38K | ||||
| Operating expense | -40.39%750.26K | -17.34%1.17M | -21.78%917.87K | -0.23%4.9M | -18.01%1.05M | 9.10%1.26M | 27.28%1.41M | -13.83%1.17M | 0.98%4.91M | 17.41%1.28M |
| Selling and administrative expenses | -34.07%651.36K | -2.19%1.09M | -16.02%811.14K | 0.99%3.93M | -19.77%859.65K | 28.07%988K | 18.45%1.11M | -12.64%965.83K | -0.74%3.89M | 38.79%1.07M |
| -Selling and marketing expense | -3.48%268.45K | -74.03%94.65K | -45.28%231.54K | 25.91%1.36M | -22.32%294.72K | 39.84%278.12K | 34.71%364.5K | 82.67%423.18K | 31.81%1.08M | 55.73%379.41K |
| -General and administrative expense | -46.06%382.91K | 32.73%995.19K | 6.81%579.6K | -8.60%2.57M | -18.37%564.92K | 23.98%709.89K | 11.88%749.77K | -37.91%542.65K | -9.35%2.81M | 30.99%692.06K |
| Research and development costs | -63.44%98.9K | -73.75%78.56K | -48.60%106.73K | -10.56%969.24K | -9.06%191.82K | -33.79%270.52K | 58.40%299.26K | -24.55%207.65K | 3.17%1.08M | -41.91%210.94K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 40.13%-64.59K | --0 |
| Operating profit | 45.90%-645.96K | 15.51%-1.17M | 27.86%-846.55K | 1.32%-4.8M | 15.27%-1.05M | -2.91%-1.19M | -24.96%-1.38M | 13.59%-1.17M | -1.31%-4.87M | -15.98%-1.24M |
| Net non-operating interest income (expenses) | -87.63%-120.85K | -276.13%-121.38K | -1,434.03%-111.2K | -1,868.16%-177.93K | -3,537.11%-74K | -1,485.67%-64.41K | -738.38%-32.27K | -204.80%-7.25K | 201.00%10.06K | 107,550.00%2.15K |
| Non-operating interest income | ---- | ---- | --0 | -87.92%9.25K | ---2.34K | --516 | -36.62%3.2K | 13.86%7.88K | 204.19%76.59K | ---- |
| Non-operating interest expense | 89.13%120.09K | 270.45%121.8K | 768.71%109.91K | 207.57%179.72K | --70.69K | --63.49K | --32.88K | --12.65K | 107.48%58.43K | ---- |
| Total other finance cost | -46.44%768 | -116.14%-419 | -47.72%1.29K | -7.71%7.47K | -93.97%965 | -64.70%1.43K | --2.6K | --2.47K | 15.96%8.09K | 635.72%16K |
| Other net income (expenses) | 100.63%14.73K | 126.57%1.14K | 76.69%-2.03K | -44.77%-23.3K | -1,103.13%-17.63K | 173.48%7.34K | 68.33%-4.31K | -252.03%-8.71K | 73.17%-16.1K | 105.12%1.76K |
| Gain on sale of security | -53.15%3.44K | 126.57%1.14K | 77.21%-3.13K | -91.85%-30.88K | -1,249.86%-20.2K | 173.48%7.34K | 68.33%-4.31K | -339.28%-13.71K | 73.17%-16.1K | 105.12%1.76K |
| Special income (charges) | --11.29K | --0 | -78.12%1.09K | --7.58K | --2.58K | --0 | --0 | --5K | --0 | --0 |
| -Less:Other special charges | ---11.29K | ---- | 78.12%-1.09K | ---7.58K | ---2.58K | ---- | ---- | ---5K | ---- | ---- |
| Income before tax | 39.89%-752.08K | 9.22%-1.29M | 19.31%-959.78K | -2.69%-5M | 7.60%-1.14M | -6.54%-1.25M | -27.28%-1.42M | 11.59%-1.19M | 0.02%-4.87M | -12.02%-1.24M |
| Income tax | -83.48K | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 39.89%-752.08K | 9.22%-1.29M | 19.31%-959.78K | -0.98%-4.92M | 14.35%-1.06M | -6.54%-1.25M | -27.28%-1.42M | 11.59%-1.19M | 0.02%-4.87M | -12.02%-1.24M |
| Net income continuous operations | 39.89%-752.08K | 9.22%-1.29M | 19.31%-959.78K | -0.98%-4.92M | 14.35%-1.06M | -6.54%-1.25M | -27.28%-1.42M | 11.59%-1.19M | 0.02%-4.87M | -12.02%-1.24M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 39.89%-752.08K | 9.22%-1.29M | 19.31%-959.78K | -0.98%-4.92M | 14.35%-1.06M | -6.54%-1.25M | -27.28%-1.42M | 11.59%-1.19M | 0.02%-4.87M | -12.02%-1.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 39.89%-752.08K | 9.22%-1.29M | 19.31%-959.78K | -0.98%-4.92M | 14.35%-1.06M | -6.54%-1.25M | -27.28%-1.42M | 11.59%-1.19M | 0.02%-4.87M | -12.02%-1.24M |
| Diluted earnings per share | 0 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.03 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.03 | 0.00%-0.01 |
| Basic earnings per share | 0 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.03 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.03 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.